Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab.
Nasr Z, Casper TC, Waltz M, Virupakshaiah A, Lotze T, Shukla N, Chitnis T, Gorman M, Benson LA, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Rensel M, Rose J, Liu C, Guye S, Manlius C, Waubant E; U.S. Network of Pediatric Multiple Sclerosis Centers.
Nasr Z, et al. Among authors: benson la.
Mult Scler Relat Disord. 2024 Apr 26;87:105647. doi: 10.1016/j.msard.2024.105647. Online ahead of print.
Mult Scler Relat Disord. 2024.
PMID: 38838422